CMND
Scisparc-Clearmind Collaboration Leads to Publication of Patent for Binge Behaviour Combination Treatment in Mexico
时间：2025-02-04 22:00:02 市场： 美股 综合
Clearmind Medicine Looks to Move Forward With Its Novel Psychedelic Meai- Based Alcohol Substitute
时间：2024-12-26 19:59:23 市场： 美股 综合
Clearmind Medicine Receives Irb Approval for Its FDA-Regulated Clinical Trial
时间：2024-12-24 19:55:00 市场： 美股 综合
Clearmind Medicine and DR Glitter Pty Ltd Sign Term Sheet for Mutual Development of Novel Psychedelic Meai- Based Alcohol Substitute in Activcrystal™ Format
时间：2024-12-16 21:37:27 市场： 美股 综合
Clearmind Medicine Announces the Notice of an International Patent Application for Pioneering Ibogaine Combination Therapy
时间：2024-09-17 04:06:00 市场： 美股 综合
Clearmind Medicine and Yissum File International Patent Application for Revolutionary Psychedelic Compounds for Ptsd Treatment
时间：2024-09-12 20:20:00 市场： 综合 美股